🤖 AI Agent Friendly: This page is available in clean token-optimized Markdown.
View as .md

health

Cooling Down

Snapshot Window: 2026-10-10 03:20 UTC · ← Back to Non-Crypto Overview

Total Posts
11
Estimated Impressions
863.4K
Bullish / Positive
3
Bearish / Negative
5
Neutral
3

Topic Engagement Summary

Total Engagement - Comments: 357, Retweets: 3219, Likes: 24167, Impressions: 863355

Verbatim Citations & Public Discussions 11 source posts analyzed

@gabtuitax · 2026-10-09T14:51:14+00:00

utilidade pública: dica da dentista

None
@interestxy · 2026-10-08T08:29:00+00:00

Here's a little secret for everyone on how to maintain mental health: don't try to interpret anything—any event, any behavior, any expression, any words, any relationship. What you see is just what you see, and what happens is just what has happened. Accept things as they truly

@sasa_ki____ · 2026-10-09T12:00:07+00:00

Lately, I've been so depressed that I want to die every day, but while I was spacing out and scrolling through my timeline, I saw people all over the world saying the same thing, and I thought this planet is done for.

@little_jake9 · 2026-10-09T23:19:28+00:00

My mom beat cancer, I'm so proud of that woman

None
@SecPrensaSV · 2026-10-09T17:55:57+00:00

The president of @ISRIelsalvador , @LigiaGallardo6 , explained that in the rehabilitation processes, electrodiagnostic medicine is incorporated as a fundamental pillar to establish with scientific evidence and improve the plans they develop according to the patients' conditions.

The image shows President Ligia Gallardo of El Salvador's Institute of Comprehensive Rehabilitation (ISRI) demonstrating electrodiagnostic equipment to medical staff, illustrating the institution's "Inversión en tecnología" (Investment in technology) initiative. The accompanying text connects to this by highlighting how this technological incorporation, specifically electrodiagnostic medicine, serves as a fundamental pillar for creating evidence-based rehabilitation plans tailored to patients' conditions.

AI visual note: The image shows President Ligia Gallardo of El Salvador's Institute of Comprehensive Rehabilitation (ISRI) demonstrating electrodiagnostic equipment to medical staff, illustrating the institution's "Inversión en tecnología" (Investment in technology) initiative. The accompanying text connects to this by highlighting how this technological incorporation, specifically electrodiagnostic medicine, serves as a fundamental pillar for creating evidence-based rehabilitation plans tailored to patients' conditions.

@ConCausaMX · 2026-10-10T00:02:45+00:00

Max portrays in a perfect manner the history of the healthcare system from the previous administration, the inhumane improvisation that, as a form of government, caused countless deaths. A destruction caused by the government and that, to this day, it has not managed to resolve.

None
@diptisunnyg1 · 2026-10-10T03:01:38+00:00

One wrong move can turn bravery into danger….Never risk your life for a moment of thrill stay safe and call a trained snake rescuer

None
@Moonlight_Blue4 · 2026-10-10T03:12:20+00:00

Si te quejas del @Tu_IMSS porque no hay medicinas, no hay consultas ni especialistas… ¡Es hora de unirnos y apoyar! #YoApoyoAlIMSS#ParoNacional

A red and black protest poster in Spanish featuring the IMSS logo, addressing a complainant by stating 'A ti derechohabiente que siempre te estás quejando del IMSS porque no hay medicinas... ES HORA DE QUE TE UNAS Y NOS APOYES,' ending with '¡APÓYANOS!'

AI visual note: A red and black protest poster in Spanish featuring the IMSS logo, addressing a complainant by stating 'A ti derechohabiente que siempre te estás quejando del IMSS porque no hay medicinas... ES HORA DE QUE TE UNAS Y NOS APOYES,' ending with '¡APÓYANOS!'

@reddit · 2026-10-08T15:15:50.409000+00:00

argenx Halts Phase 3 Sjogren's Disease Trial After Futility Review, Stock Drops 15% argenx discontinued its Phase 3 UNITY study of subcutaneous efgartigimod in moderate-to-severe Sjogren's disease after an independent data monitoring committee determined the trial could not meet its primary endpoint, the Week 48 clinESSDAI score, at an interim futility review. No new safety signals were identified. The company said the decision was based solely on the trial's inability to demonstrate efficacy at the prespecified threshold. The news sent argenx shares down roughly 13 to 15.6 percent in premarket trading on October 8, making it one of the largest premarket decliners of the session. The Sjogren's indication had been a closely watched expansion target for efgartigimod, which is already approved in myasthenia gravis.

@BethFratesMD · 2026-10-10T03:00:13+00:00

Goodnight! Wishing you a sound sleep. If you are having trouble relaxing, try deep breathing or list 3 things you are grateful for. Another #relaxation technique is to think of someone you #love who has always supported you, and why you love them so much.

None
@ryotsun1962 · 2026-10-10T03:23:11+00:00

フルマラソン近いのに膝窩が痛い 30km位から支障出てくるやつだよほんとやめて